ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 595

A Genomewide Association Study of Anterior Uveiti

Dorith Claushuis1, Adrian Cortes2, Linda A. Bradbury1, Tammy M. Martin3, James T. Rosenbaum4, John D. Reveille5, Paul Wordsworth6, Jennifer Pointon6, Australo-Anglo-American Spondyloarthritis Consortium7, David Evans8, Paul Leo2, Pamela Mukhopadhyay2 and Matthew A. Brown2, 1Human Genetics Group, The University of Queensland Diamantina Institute, Brisbane, Australia, 2Human Genetics Group, The University of Queensland Diamantina Insititute, Brisbane, Australia, 3Ophthalmology/L467AD, Oregon Health & Science Univ, Portland, OR, 4Arthritis and Rheumatic diseases, Oregon Health and Science University, Portland, OR, 5Internal Medicine/Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX, 6Ndorms, Nuffield Orthopaedic Centre, Oxford, United Kingdom, 7Houston, TX, 8School of Social and Community Medicine, Bristol University, Bristol, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and genomics

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthritis and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Anterior uveitis (AU) is the most common extra-articular manifestation of ankylosing spondylitis (AS), occurring in up to 30-40% of AS cases.  The aim of the current study was to investigate clinical associations of AS, and to identify genes associated with the risk of developing AU.     

Methods: 972 AS cases with AU (AS+AU+) and 1404 AS cases without AU (AS+AU-) were available for study.  All cases were of white European descent. A genomewide association study was performed using SNP data from the TASC and TASC-WTCCC2 AS studies, 291,537 SNPs being available in the merged dataset.  Case-control analysis comparing the AS+AU+ and AS+AU- cohorts was performed using Eigenstrat to control for population stratification effects.

Results:  Male and female AS cases were equally likely to develop AU.  As expected, AU complicating AS was strongly associated with AS disease duration (beta=0.027, P<10-6).  No association was seen with age, independent of AS disease duration.  Considering AS+AU+ cases in comparison with AS+AU- cases, no SNP achieved genomewide significance.  Three loci showed suggestive association with AU.  At chromosome 6q26, two SNPs in the PARK2 gene achieved P<10-5 (rs2849576, p=7.6×10-6; rs13205287, p=2.0×10-6).   Five SNPs (rs379796, rs419519, rs445890, rs452186, rs45218) in an intergenic region on chromosome 4q33 achieved P=9.0×10-6-9.5×10-6.  Association was noted with HLA-B27 (antigen carriage, odds ratio 2.58, P=5.6×10-8).  There was a marginal association of B27-homozygosity in this analysis (odds ratio 2.1, P=0.06).  No known AS locus was differentially associated in AS+AU+ cases in comparison with AS+AU- cases.

Conclusion: This analysis found that with the exception of HLA-B27, no differences were identified between AS+AU+ and AS+AU- cases.  The study was adequately powered to identify moderately large genetic effects, but not small-moderate genetic effects for which larger studies will be required.  Further, as all patients studied have AS, whether genetic associations of AS-AU+ cases are different to those of AS+AU+ remains unclear.  Nonetheless, these findings suggest that AU has very similar genetic risk factors to AS, and therefore that they likely share similar aetiopathogenisis.


Disclosure:

D. Claushuis,
None;

A. Cortes,
None;

L. A. Bradbury,
None;

T. M. Martin,
None;

J. T. Rosenbaum,
None;

J. D. Reveille,
None;

P. Wordsworth,
None;

J. Pointon,
None;

D. Evans,
None;

P. Leo,
None;

P. Mukhopadhyay,
None;

M. A. Brown,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-genomewide-association-study-of-anterior-uveiti/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology